Entourage Health Corp. announced today that it will file its fourth quarter and full-year 2021 financial statements and management’s discussion and analysis after-market on Monday May 2, 2022.

Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.

Pre-roll products available at Ontario retail stores via the Company’s craft brand Royal City Cannabis Co., with $1 of every pre-roll sold going to the advancement of Cannabis Amnesty’s initiatives

Entourage Health Corp. is pleased to announce the appointment of Vaani Maharaj, a seasoned financial executive with broad experience in corporate finance, healthcare and consumer-packaged goods (CPG).

On this International Women’s Day, the Company proudly spotlights its all-female trade and brand marketing team behind the 2022 launch of “Just add Color” anchored in colour theory

Company also provides a corporate update and confirms George Scorsis as permanent CEO

Includes Ontario launch of specialty concentrate product “Pedro’s Sweet Sativa Live Sugar”; debut of high-THC, rare cultivar “Space Cake”; and “Black Sugar Rose 10-pack Pre-rolls”

Entourage Health issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022.

Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed Medicinal

Company also confirms its certification as an Ontario Living Wage Employer, becoming one of only three cannabis cultivators with this distinction

Company partners with Olli Brands Inc. to develop and curate a suite of premium CBD and THC soft chew products for release in its medical channel starting late November 2021

Entourage Health Corp. announced today its financial results for the three and nine months ended September 30, 2021.

Entourage Heath is pleased to announce it has further strengthened its executive team with strategic appointments in the areas of commercial sales, marketing, and business development as well as product development, cultivation and supply chain.

Closing of deal merges craft brand Royal City Cannabis Co. into Entourage’s product portfolio

Entourage Health Corp.is pleased to announce its preliminary unaudited total revenues of $14.7 million(1) for the three months ended September 30, 2021, representing another quarter of sequential record sales growth across its adult-use and medical sales channels.

Entourage Health Corp., today announces that, as a result of a continuous disclosure review conducted by staff of the Ontario Securities Commission (“OSC”), the staff of the Corporate Finance Branch requested that the Company refile its management's discussion and analysis (“MD&A”) for the interim periods ended March 31, 2021 and June 30, 2021 and its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2021 (collectively, the "Revised Financial Disclosure").

Innovative suite of Mary’s line-up produced locally now includes Transdermal Patches in CBD, THC and 1:1 formulations that offer a novel, alternative path to cannabinoid delivery

Canada’s largest cannabis retailer Fire & Flower expands private-label portfolio with “Revity CBD Softgels” products added to its self-care lineup, produced exclusively by Entourage Health

Entourage Health Corp. announced that effective at market open on September 1, 2021, the OTCQX market ticker symbol for the Company’s common shares will change from “WDDMF” to “ETRGF”.

Entourage holds exclusive rights to sell, market and distribute Boston Beer-branded and licensed non-alcoholic, cannabis beverages produced by Althea’s subsidiary Peak Processing